Atlas Trials

Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children

Clinical trial NCT00192322 · COMPLETED

Trial details

NCT number
NCT00192322
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Influenza
Start date
2001-09-01
Primary completion
2001-12-01
Enrollment
173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.